Andrew Card Joins BrainStorm Cell Therapeutics Inc.’s Business Advisory Board

NEW YORK & PETACH TIKVAH, Israel--(BUSINESS WIRE)--BrainStorm Cell Therapeutics Inc. (OTCQB: BCLI), a leading developer of adult stem cell technologies and therapeutics, announced today that Andrew Card, former White House Chief of Staff, has been appointed to the company's Business Advisory Board.
MORE ON THIS TOPIC